Cargando…

Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver

BACKGROUND: With the continued integration of engineered nanomaterials (ENMs) into everyday applications, it is important to understand their potential for inducing adverse human health effects. However, standard in vitro hazard characterisation approaches suffer limitations for evaluating ENM and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Llewellyn, Samantha V., Conway, Gillian E., Zanoni, Ilaria, Jørgensen, Amalie Kofoed, Shah, Ume-Kulsoom, Seleci, Didem Ag, Keller, Johannes G., Kim, Jeong Won, Wohlleben, Wendel, Jensen, Keld Alstrup, Costa, Anna, Jenkins, Gareth J. S., Clift, Martin J. D., Doak, Shareen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240362/
https://www.ncbi.nlm.nih.gov/pubmed/34183029
http://dx.doi.org/10.1186/s12951-021-00938-w
_version_ 1783715200655949824
author Llewellyn, Samantha V.
Conway, Gillian E.
Zanoni, Ilaria
Jørgensen, Amalie Kofoed
Shah, Ume-Kulsoom
Seleci, Didem Ag
Keller, Johannes G.
Kim, Jeong Won
Wohlleben, Wendel
Jensen, Keld Alstrup
Costa, Anna
Jenkins, Gareth J. S.
Clift, Martin J. D.
Doak, Shareen H.
author_facet Llewellyn, Samantha V.
Conway, Gillian E.
Zanoni, Ilaria
Jørgensen, Amalie Kofoed
Shah, Ume-Kulsoom
Seleci, Didem Ag
Keller, Johannes G.
Kim, Jeong Won
Wohlleben, Wendel
Jensen, Keld Alstrup
Costa, Anna
Jenkins, Gareth J. S.
Clift, Martin J. D.
Doak, Shareen H.
author_sort Llewellyn, Samantha V.
collection PubMed
description BACKGROUND: With the continued integration of engineered nanomaterials (ENMs) into everyday applications, it is important to understand their potential for inducing adverse human health effects. However, standard in vitro hazard characterisation approaches suffer limitations for evaluating ENM and so it is imperative to determine these potential hazards under more physiologically relevant and realistic exposure scenarios in target organ systems, to minimise the necessity for in vivo testing. The aim of this study was to determine if acute (24 h) and prolonged (120 h) exposures to five ENMs (TiO(2), ZnO, Ag, BaSO(4) and CeO(2)) would have a significantly different toxicological outcome (cytotoxicity, (pro-)inflammatory and genotoxic response) upon 3D human HepG2 liver spheroids. In addition, this study evaluated whether a more realistic, prolonged fractionated and repeated ENM dosing regime induces a significantly different toxicity outcome in liver spheroids as compared to a single, bolus prolonged exposure. RESULTS: Whilst it was found that the five ENMs did not impede liver functionality (e.g. albumin and urea production), induce cytotoxicity or an IL-8 (pro-)inflammatory response, all were found to cause significant genotoxicity following acute exposure. Most statistically significant genotoxic responses were not dose-dependent, with the exception of TiO(2). Interestingly, the DNA damage effects observed following acute exposures, were not mirrored in the prolonged exposures, where only 0.2–5.0 µg/mL of ZnO ENMs were found to elicit significant (p ≤ 0.05) genotoxicity. When fractionated, repeated exposure regimes were performed with the test ENMs, no significant (p ≥ 0.05) difference was observed when compared to the single, bolus exposure regime. There was < 5.0% cytotoxicity observed across all exposures, and the mean difference in IL-8 cytokine release and genotoxicity between exposure regimes was 3.425 pg/mL and 0.181%, respectively. CONCLUSION: In conclusion, whilst there was no difference between a single, bolus or fractionated, repeated ENM prolonged exposure regimes upon the toxicological output of 3D HepG2 liver spheroids, there was a difference between acute and prolonged exposures. This study highlights the importance of evaluating more realistic ENM exposures, thereby providing a future in vitro approach to better support ENM hazard assessment in a routine and easily accessible manner. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-00938-w.
format Online
Article
Text
id pubmed-8240362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82403622021-06-30 Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver Llewellyn, Samantha V. Conway, Gillian E. Zanoni, Ilaria Jørgensen, Amalie Kofoed Shah, Ume-Kulsoom Seleci, Didem Ag Keller, Johannes G. Kim, Jeong Won Wohlleben, Wendel Jensen, Keld Alstrup Costa, Anna Jenkins, Gareth J. S. Clift, Martin J. D. Doak, Shareen H. J Nanobiotechnology Research BACKGROUND: With the continued integration of engineered nanomaterials (ENMs) into everyday applications, it is important to understand their potential for inducing adverse human health effects. However, standard in vitro hazard characterisation approaches suffer limitations for evaluating ENM and so it is imperative to determine these potential hazards under more physiologically relevant and realistic exposure scenarios in target organ systems, to minimise the necessity for in vivo testing. The aim of this study was to determine if acute (24 h) and prolonged (120 h) exposures to five ENMs (TiO(2), ZnO, Ag, BaSO(4) and CeO(2)) would have a significantly different toxicological outcome (cytotoxicity, (pro-)inflammatory and genotoxic response) upon 3D human HepG2 liver spheroids. In addition, this study evaluated whether a more realistic, prolonged fractionated and repeated ENM dosing regime induces a significantly different toxicity outcome in liver spheroids as compared to a single, bolus prolonged exposure. RESULTS: Whilst it was found that the five ENMs did not impede liver functionality (e.g. albumin and urea production), induce cytotoxicity or an IL-8 (pro-)inflammatory response, all were found to cause significant genotoxicity following acute exposure. Most statistically significant genotoxic responses were not dose-dependent, with the exception of TiO(2). Interestingly, the DNA damage effects observed following acute exposures, were not mirrored in the prolonged exposures, where only 0.2–5.0 µg/mL of ZnO ENMs were found to elicit significant (p ≤ 0.05) genotoxicity. When fractionated, repeated exposure regimes were performed with the test ENMs, no significant (p ≥ 0.05) difference was observed when compared to the single, bolus exposure regime. There was < 5.0% cytotoxicity observed across all exposures, and the mean difference in IL-8 cytokine release and genotoxicity between exposure regimes was 3.425 pg/mL and 0.181%, respectively. CONCLUSION: In conclusion, whilst there was no difference between a single, bolus or fractionated, repeated ENM prolonged exposure regimes upon the toxicological output of 3D HepG2 liver spheroids, there was a difference between acute and prolonged exposures. This study highlights the importance of evaluating more realistic ENM exposures, thereby providing a future in vitro approach to better support ENM hazard assessment in a routine and easily accessible manner. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-00938-w. BioMed Central 2021-06-28 /pmc/articles/PMC8240362/ /pubmed/34183029 http://dx.doi.org/10.1186/s12951-021-00938-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Llewellyn, Samantha V.
Conway, Gillian E.
Zanoni, Ilaria
Jørgensen, Amalie Kofoed
Shah, Ume-Kulsoom
Seleci, Didem Ag
Keller, Johannes G.
Kim, Jeong Won
Wohlleben, Wendel
Jensen, Keld Alstrup
Costa, Anna
Jenkins, Gareth J. S.
Clift, Martin J. D.
Doak, Shareen H.
Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver
title Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver
title_full Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver
title_fullStr Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver
title_full_unstemmed Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver
title_short Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver
title_sort understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3d models of the human liver
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240362/
https://www.ncbi.nlm.nih.gov/pubmed/34183029
http://dx.doi.org/10.1186/s12951-021-00938-w
work_keys_str_mv AT llewellynsamanthav understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT conwaygilliane understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT zanoniilaria understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT jørgensenamaliekofoed understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT shahumekulsoom understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT selecididemag understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT kellerjohannesg understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT kimjeongwon understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT wohllebenwendel understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT jensenkeldalstrup understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT costaanna understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT jenkinsgarethjs understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT cliftmartinjd understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver
AT doakshareenh understandingtheimpactofmorerealisticlowdoseprolongedengineerednanomaterialexposureongenotoxicityusing3dmodelsofthehumanliver